Menachem Weiner, MD

Insurance Information

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Scopus h-index:15

Article:42

Review Article:24

Letter:7

Editorial:8

Chapter:3

Recent Artifacts

• A Call to Develop More Anesthesiologist Physician Leaders of Healthcare Organizations
• Plasma Renin Activity Increases With Cardiopulmonary Bypass and is Associated With Vasoplegia After Cardiac Surgery
• The Year in Cardiothoracic and Vascular Anesthesia: Selected Highlights from 2022
• 2022 HRS expert consensus statement on evaluation and management of arrhythmic risk in neuromuscular disorders
• Dealing With the Right Side: Carcinoid Heart Disease
• Type A Aortic Dissection After a Transcatheter Aortic Valve Replacement in a Prohibitive Surgical Risk Candidate
• Leadless pacemaker implantation under direct visualization during valve surgery
• The Year in Cardiothoracic and Vascular Anesthesia: Selected Highlights from 2021
• Temporary mechanical circulatory support devices: practical considerations for all stakeholders
• Using near-infrared spectroscopy myocardial oximetry to monitor myocardial oxygen balance in a swine model of cardiac surgery: a descriptive study

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Weiner did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.